Semiquantitative evaluation of hepatic fibrosis by measuring tissue hydroxyproline

Hepato-Gastroenterology

Volumn 45, Issue 24, 1998, Pages 2261-2264

  Toyoki, Yoshikazu ^a   Sasaki, Mutsuo ^a   Narumi, Shunji ^a   Yoshihara, Syuichi ^a   Morita, Takayuki ^a   Konn, Mitsuru ^a  

^a NONE

Author keywords

Fully automated liquid chromatograph; Hepatic fibrosis; Hydroxyproline

Indexed keywords

8 AZAGUANINE; COLLAGEN; DIMETHYLNITROSAMINE; EOSIN; HEMATOXYLIN; HYDROXYPROLINE; PARAFFIN;

AMINO ACID ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOG; FEMALE; LIQUID CHROMATOGRAPHY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; TISSUE LEVEL;

EID: 0032415451     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Engstrom LC: Concentration of sodium hyaluronate in serum. Scand J Clin Lab Invest 1985; 45:497-504.
2. Ueno T, Inuzuka S, Torimura T, Shakado S, Sakata R, Sakamoto M, Sata M, Yoshida H, Tanikawa K: Serum hyaluronate in liver diseases. Acta Hepatologica Japonica 1991; 32:767-774 (In Japanese).
3. Hahn E, Wick G, Pencev D, Timpl R: Distribution of basement membrane proteins in normal and fibrotic human liver:@ECollagen type IV, laminin, and fibronectin. Gut 1980; 21:63-71.
4. Niemela O, Risteli L, Sotaniemi EA, Risteli J: Type IV collagen and laminim-related antigens in human serum in alcoholic liver disease. Eur J Clin Invest 1985; 15:132-137.
5. Ueno T, Inuzuka S, Torimura T, Oohira H, Ko H, Obata K, Sata M, Yoshida H, Tanikawa K: Significance of serum type IV collagen levels in various liver diseases. Scand J Gastroenterol 1992; 27:513-520.
6. Jiang Z, You DY, Chen XC, Wu J: Monitoring of serum markers of fibrosis during CC14-induced liver damage -effects of antifibrotic agents. J Hepatol 1992; 16:282-289.
7. Savolainen ER, Brocks D, Ala-Kokko L, Kivirikko KI: Serum concentrations of the N-terminal propeptide of type Vα procollagen and two type Wa collagen fragments and gene expression of the respective collagen types in liver in rats with dimethylnitrosamine-induced hepatic fibrosis. Biochem J 1988; 249:753-757.
8. Gabrielli GB, Faccioli G, Casaril M, Capra F, Bonazzi L, Falezza G, Tomba A, Baracchino F, Corrocher R: ProcollagenVα peptide and fibronectin in alcoholic related chronic liver disease: Correlation with morphological features and biochemical tests. Clin Chim Acta 1989; 179:315-322.
9. McCullough A, Stassen WN, Weisseer RH, Czaja AZ: Serum type Vα procollagen peptide concentration in severe chronic active hepatitis: relationship to cirrhosis and disease activity. Hepatol 1987; 7:49-54.
10. Okuno H, Hazama H, Murase T, Shiozaki Y, Sameshima Y: Drug metabolizing activity in rats with chronic liver injury induced by carbon tetrachloride: Relationship with the content of hydroxyproline in the liver. Jpn J Pharmacol 1986; 41:363-371.
11. Madden JW, Gertman PM, Peacock EE: Dimethylnitrosamine-induced hepatic cirrhosis: A new canine model of an ancient human disease. Surgery 1970; 68:260-268.
12. Kohno A, Mizumoto R, Honjo I: Changes after major resection of experimental cirrhotic liver. Am J Surg 1977; 134:248-252.
13. Koda M, Murawaki Y, Hirayama C: Free and small peptide-bound [14C]hydroxyproline synthesis in rat liver in vitro in CCl4-induced hepatic fibrosis. Biochem Biophys Res Commun 1988; 151:1128-1135.
14. Toyoki Y, Yoshihara S, Sasaki M, Totsuka E, Akaishi S, Seino K, Narumi S, Konn M: Serial change of hepatocytes and extracellular matrix in regenerating liver. Jpn J Gastroenterol Surg 1993; 26:2377 (In Japanese).
15. Haney A, Peacock EE, Madden JW: Liver regeneration and hepatic collagen deposition in rats with dimethylnitrosamine-induced cirrhosis. Ann Surg 1972; 175:863-869.